Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for energy industry professionals · Tuesday, October 23, 2018 · 465,981,696 Articles · 3+ Million Readers

Immunotech Laboratories, Inc. Receives Invitation to the 2018 Asia-Pacific Precision Medicine Forum

/EIN News/ -- Monrovia, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Immunotech Laboratories, Inc. f/k/a Eco-Petroleum Solutions, Inc. (OTC Markets "ECPO" or the “Company”) announced that the Company, at the recommendation of Hongxiang Hui, MD, Ph.D,  the Company’s recent addition to the Advisory Board, has received an invitation to attend the 2018 Asia-Pacific Precision Medicine Forum (“APPM”) to be held in Bo’ao, Hainan, PR, China from January 17 through January 19th, 2018. Dr. Hui will also be attending.

The invitation states that “APPM is organized and hosted by Hainan provincial Health and Family Planning Commission and Asia Pacific Precision Medical Industry Alliance, and co-sponsored by Hainan provincial government and dozen Asian-Pacific countries, as well as more than one hundred entities related to biotechnology, precise medicine, hospitals, pharmaceutical and beauty entrepreneurial and wellness business. The conference will provide a platform for research and practitioners to share their research and best practices as well as products with the broader precise medicine community. This annual ceremony will cover Asia Pacific Precision Medical Industry Alliance, Top Ten Beauty Agency Awards Ceremony, Artificial Intelligence & Big Data-based Precision Medical Salon, Asia Pacific Precision Medical Wealth Forum, Boao Lecheng Medical Pioneer Area Visiting, etc.”

The organizers expect over 15 national Consulate General, 3,000 + precision medical health industry elites, 100+ global experts and Nobel laureates, 20 + provincial and municipal Health and Family Planning Commissions, 100+ chambers of commerce association health industry parks, and 1,000+ medical beauty dealers will join the conference. Hundreds of international and national news media will keep track of the progress and achievements of the conference.

“I am honored that the organizers of the APPM have invited the Company to attend this prestigious forum and look forward to the Company being represented where its achievements can be discussed with the attendees in this prestigious international setting. Dr. Hui’s experience and reputation in this venue is an enormous asset to the Company,” stated Harry Zhabilov, CEO.

About Immunotech;

Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Immunotech is committed to creating drugs for the better health of mankind.

Immunotech’s flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective in the treatment of HIV/AIDS. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system.

Safe Harbor Statement: This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Eco Petroleum Solutions, Inc. / Immunotech Laboratories, Inc. from time to time in its periodic reports filed with the SEC. IPF is not approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world.

While Eco Petroleum / Immunotech Laboratories believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Eco Petroleum / Immunotech Laboratories to establish the efficacy of IPF in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of IPF in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests on time or at all, and the successful outcome of such studies or tests.

Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, Eco Petroleum / Immunotech Laboratories or any other person that the objectives and plans of Eco Petroleum / Immunotech Laboratories will be achieved should not regard the forward-looking statements as a representation.

IR Contact:
                    Immunotech Laboratories, Inc.
                    120 W Pomona Ave
                    Monrovia, CA 91016
                    Phone: (626) 538-4779
                    Fax: (626) 538-4779
                    

Powered by EIN News